Blog
7 in 10 Digestive Cancer Patients Were Already Malnourished — and the Support Program Built to Help Fell Short
A French cancer center scored digestive cancer patients for nutritional frailty and built them a dietitian, exercise, and palliative care pathway. A new study reports 71% were malnourished before treatment — and fewer than half finished the support program.
Two Pills, No Chemo: Tumors Shrank in 82% of Pancreatic Cancer Patients in an Early Trial
In an early trial presented at ESMO 2026, two once-daily pills — vopimetostat and daraxonrasib — shrank tumors in 82% of patients with a genetic subtype of advanced pancreatic cancer, most on their third line of therapy. What the results mean, the side effects, and the Phase 3 test that comes next.